About Magnolia Innovation

Rony Ben-David is a seasoned Director at Magnolia Innovation, leading a dynamic team of researchers and consultants. With nearly 30 years of experience in market research and consulting, Rony specializes in the pharmaceutical and life sciences industry, catering to a wide range of clients from small bio-techs to large pharmaceutical companies.

Throughout his career, Rony has excelled in both qualitative and quantitative market research, covering all stages of a compound’s lifecycle, from pre-clinical to post-launch strategies. He has conducted thousands of interviews, focus groups, and surveys, engaging with patients, caregivers, healthcare professionals, and Key Opinion Leaders (KOLs) globally. Rony’s quantitative expertise encompasses various study types and analytical techniques, including concept testing, demand studies, usability testing, and segmentation studies.

While focusing on rare diseases and oncology at Magnolia, Rony also possesses extensive experience in other therapeutic areas such as cardiology, diabetes, HIV, and women’s health. Known for his ability to transform complex data into meaningful insights, Rony has established a stellar reputation as a client partner committed to delivering excellence.

Before joining Magnolia, Rony held positions at GfK, a prominent global research conglomerate, as well as smaller consultancies. He has led research teams and contributed to task forces focused on employee development, process improvement, and client service. Rony holds a Bachelor of Science degree in Marketing from the City University of New York and has completed various post-graduate programs, enhancing his tactical, industry-specific knowledge and strategic leadership abilities.

With his wealth of experience, profound expertise, and client-focused approach, Rony remains a sought-after market research consultant for pharmaceutical and life sciences companies in need of strategic guidance and valuable market insights.